The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within th...
textabstractIn 2016, the third version of guidelines for the diagnosis and treatment of neuroendocri...
Neuroendocrine tumors (NET) are malignant solid tumors that arise in hormone-secreting tissue of the...
Systemic chemotherapy is indicated in progressive or bulky advanced pancreatic neuroendocrine tumors...
The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to impr...
The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to impr...
This expert consensus document represents an initiative by the European Neuroendocrine Tumor Society...
This expert consensus document represents an initiative by the European Neuroendocrine Tumor Society...
In recent years the WHO classification of neuroendocrine neoplasms (NEN) has evolved. Nomenclature a...
Despite efforts from various endoscopy societies, reporting in the field of endoscopy remains extrem...
Professional as well as patient-oriented societies have contributed significantly to the development...
Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NE...
Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NE...
The European Neuroendocrine Tumor Society (ENETS) proposed standard of care guidelines for pathology...
The European Neuroendocrine Tumor Society (ENETS) proposed standard of care guidelines for pathology...
collection and content of documented data vary consid-erably. Therefore, comparison of data from dif...
textabstractIn 2016, the third version of guidelines for the diagnosis and treatment of neuroendocri...
Neuroendocrine tumors (NET) are malignant solid tumors that arise in hormone-secreting tissue of the...
Systemic chemotherapy is indicated in progressive or bulky advanced pancreatic neuroendocrine tumors...
The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to impr...
The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to impr...
This expert consensus document represents an initiative by the European Neuroendocrine Tumor Society...
This expert consensus document represents an initiative by the European Neuroendocrine Tumor Society...
In recent years the WHO classification of neuroendocrine neoplasms (NEN) has evolved. Nomenclature a...
Despite efforts from various endoscopy societies, reporting in the field of endoscopy remains extrem...
Professional as well as patient-oriented societies have contributed significantly to the development...
Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NE...
Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NE...
The European Neuroendocrine Tumor Society (ENETS) proposed standard of care guidelines for pathology...
The European Neuroendocrine Tumor Society (ENETS) proposed standard of care guidelines for pathology...
collection and content of documented data vary consid-erably. Therefore, comparison of data from dif...
textabstractIn 2016, the third version of guidelines for the diagnosis and treatment of neuroendocri...
Neuroendocrine tumors (NET) are malignant solid tumors that arise in hormone-secreting tissue of the...
Systemic chemotherapy is indicated in progressive or bulky advanced pancreatic neuroendocrine tumors...